Choose a country to view content specific to your location

American Society of Human Genetics (ASHG) 2025 Annual Meeting

Home » Life Science » Events & Tradeshows » Immuno » American Society of Human Genetics (ASHG) 2025 Annual Meeting

14 — 18 October 2025

Join us at the American Society of Human Genetics (ASHG 2025) Annual Meeting where the world’s leading geneticists, genetics research and biotechnology companies will be gathered to collaborate and discuss the latest cutting-edge advancements in the human genetics and genomics industry.
Advancing Molecular Diagnostics with Smarter Reagent Solutions
We’ll be showcasing a comprehensive portfolio of high-performance enzymes and master mixes designed for reliability, sensitivity, and workflow efficiency across applications such as liquid biopsy, tNGS, NGS, and genotyping.

Our Reagent Solutions Are Engineered To:

• Enhance stability, even under variable temperature conditions

• Improve sensitivity for accurate, reproducible results

• Streamline workflows to save hands-on time and reduce complexity

Precision Oncology Solutions are Driving the Future of Cancer Diagnostics

Early detection demands more. Our high-performance reagents enable exceptional sensitivity, specificity, and scalability—supporting precision oncology assays across qPCR, targeted NGS, and WGS. From early detection and tumor profiling to recurrence monitoring, our solutions are built to advance cancer diagnostics and improve patient outcomes.

Why It Matters
By improving assay performance and flexibility, our technologies help you:

• Accelerate development timelines

• Expand access to global markets

• Seamlessly transition from R&D to market launch

• Decentralized testing & rapid assay development

• Enable the next breakthroughs in precision medicine

Visit us at Booth #1243 during ASHG 2025 to see how our solutions can simplify workflows and support your next generation of molecular innovations.

Contact us to schedule a meeting and learn how our reagents—and formulation expertise—can accelerate your assay development pipeline.

Related Content

Molecular Custom Services

Stabilization of molecular reagents for qPCR, Isothermal Amplifications, and NGS 

We help assay developers create ambient temperature-stable assays without compromising performance—thanks to our specialized stabilization services for key molecular reagents like enzymes, dUTPs, and master mixes.







Solving Enzyme Stability by Tackling Glycerol-Free Formulation Challenges

Developing glycerol-free enzymes requires a strategic approach that extends beyond simply removing glycerol.
Meridian has engineered high-performing glycerol-free enzymes for PCR, LAMP, and NGS, ensuring superior activity and stability after lyophilization.






 

Shaping the Future of Precision Oncology: A Comparative Analysis of qPCR, Targeted NGS, and Whole Genome Sequencing

As precision medicine in oncology advances, selecting the right genomic analysis method is key to obtaining accurate and actionable insights.

LEARN ABOUT:
How qPCR, targeted NGS, and whole-genome sequencing compare
The advantages and limitations of each approach
Real-world assay examples of the technologies in clinical oncology settings
Speaker: Dale Clash, Strategic Marketing Manager (Molecular)

Improve Your Assay Stability

Simplify Your Supply Chain & Accelerate Your Assay Development

• Preserve Assay Integrity

• Streamlined Workflows

• Single-source Solution

• Extend Shelf-life & Ease Logistics

• Cost Savings

Solutions for Next Generation Sequencing (NGS)

Democratizing NGS sequencing through innovative reagents

With the reduction in cost and increased portability of sequencing instruments, consumables, and data analysis tools, NGS is becoming more accessible, affordable, and user-friendly for a wider range of researchers, clinicians, and industries

Unlocking Precision in Liquid Biopsy with High-Sensitivity qPCR

qPCR Master Mixes for Oncology Testing of Crude Blood, Urine, Stool and Saliva Samples

Liquid biopsy samples contain powerful, real-time insights into disease progression,treatment response, and therapeutic resistance.



Get In Touch With A Specialist

Get in Touch